In this study, by investigating the roles of RGS12 on TAMs from mice with oral cancer, we revealed that RGS12 is an essential factor to control immune activation in oral cancer by regulating macrophage polarization and ciliogenesis via MYCBP2/KIF2A. Here, MYCBP2 is linked to lip and oral cavity carcinoma.